Relationship of chronic neurogenic pain and fibrinolysis in the blood of patients with melanoma.

Authors

null

Ludmila Ya. Rozenko

Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation

Ludmila Ya. Rozenko , Elena M. Frantsiyants , Valeria A. Bandovkina , Yulia A. Pogorelova , Natalia D. Cheryarina , Marina A. Gusareva , Oleg I. Kit

Organizations

Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation

Research Funding

No funding received
None

Background: The plasminogen regulation system is critical in triggering proteolysis to cleave the extracellular matrix and basement membrane. The “uPA-uPAR” system is involved in extravascular fibrinolysis and is responsible for the formation of plasmin associated with invasion and metastasis. The purpose of the study was to analyze levels of factors of the plasminogen regulation system in the blood of patients with cutaneous melanoma (M) and chronic neurogenic pain (CNP). Methods: Blood levels of PAP, uPA, uPAR and PAI-1 were measured by ELISA in patients with Т3-4NxM0 melanoma: 21 women with CNP (pelvic pain - 7, osteochondrosis – 14), mean age 67.2±2.7 years; 17 men with CNP (osteochondrosis), mean age 65.6±3.1 years. The control group included patients with melanoma similar in age, gender and disease stages without CNP. Results: Blood levels of PAP in women with M+CNP were twice higher than in patients with M without CNP, the levels in men with M+CNP did not change; uPA content increased in both women and men with M without CNP by 1.4 and 1.5 times, uPA activity was elevated only in women by 2.4 times, in men it was reduced by 2 times; uPAR was increased by 1.5 times in women and men compared to the values in both female and male patients with M without CNP. PAI-1 content in women and men with M+CNP was similar to control values, and its activity was increased in women by 1.5 times and decreased in men by 2.5 times. Conclusions: The study gives significant additional information on the effect of CNP on relationships in the plasminogen activation system in a combination of cutaneous melanoma and CNB showing marked gender differences. The results should be taken into account in the special treatment of patients with melanoma.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Publication Only

Session Title

Publication Only: Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Citation

J Clin Oncol 38: 2020 (suppl; abstr e22085)

DOI

10.1200/JCO.2020.38.15_suppl.e22085

Abstract #

e22085

Abstract Disclosures

Similar Abstracts

First Author: Inga Movlievna Kotieva

Abstract

2020 ASCO Virtual Scientific Program

Effect of chronic neurogenic pain on blood levels of hormones in patients with melanoma depending on their gender.

First Author: Viktoria V. Pozdnyakova

Abstract

2023 ASCO Annual Meeting

The impact of music therapy on opioid use in cancer survivors with chronic pain.

First Author: Joke Bradt

First Author: Joud El Dick